PharMerica CORP Retained Earnings
PharMerica CORP had Retained Earnings of $185.10 million as of 2017-09-30, per its 10-Q filed 2017-11-09.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-11-09
- 2017-09-30: Retained Earnings (Accumulated Deficit) $185.10M.
- 2017-06-30: Retained Earnings (Accumulated Deficit) $181.90M.
- 2017-03-31: Retained Earnings (Accumulated Deficit) $177.20M.
- 2016-12-31: Retained Earnings (Accumulated Deficit) $173.70M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2017-09-30 | $185.10M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $181.90M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $177.20M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $173.70M 10-Q · filed 2017-11-09 |
| 2016-09-30 | $166.00M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $158.70M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $156.20M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $152.10M 10-K · filed 2017-02-24 |
| 2015-09-30 | $131.90M 10-Q · filed 2015-11-06 |
| 2015-06-30 | $128.90M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $126.60M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $117.00M 10-K · filed 2016-02-26 |
| 2014-09-30 | $113.80M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $105.30M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $115.00M 10-Q · filed 2014-05-01 |
| 2013-12-31 | $110.20M 10-K · filed 2015-03-02 |
| 2013-09-30 | $105.80M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $112.00M 10-Q · filed 2013-08-02 |
| 2013-03-31 | $101.80M 10-Q · filed 2013-05-01 |
| 2012-12-31 | $91.30M 10-K · filed 2014-02-28 |
| 2012-09-30 | $87.60M 10-Q · filed 2012-11-01 |
| 2012-06-30 | $81.60M 10-Q · filed 2012-08-02 |
| 2012-03-31 | $74.00M 10-Q · filed 2012-05-02 |
| 2011-12-31 | $68.40M 10-K · filed 2013-02-07 |
| 2011-09-30 | $60.50M 10-Q · filed 2011-11-03 |
| 2011-06-30 | $55.70M 10-Q · filed 2011-08-04 |
| 2010-12-31 | $45.00M 10-K · filed 2012-02-09 |